ARC-031

N/A

Report date: 2024/06/28 16:39:01
NME

Base Information

Drug NameARC-031
Drug Alias NameARC-031ARC-031SR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockers
TargetsVoltage-gated L-type calcium channel
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArcher Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcher Pharmaceuticals Inc
Inactive CompaniesArcher
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A